CT-based Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma ≤ 3 cm: Enhancing Deep Learning Specificity by Waiving Chest Wall Information.

Journal: Annals of surgical oncology
Published Date:

Abstract

BACKGROUND: Accurate preoperative prediction of visceral pleural invasion (VPI) in lung adenocarcinoma is essential for guiding surgical decision-making. However, existing prediction models often sacrifice specificity when optimized for high sensitivity, increasing the risk of overtreatment. This study aimed to develop a computed tomography (CT)-based deep learning (DL) model that improves specificity by excluding chest wall information. METHODS: We retrospectively enrolled 835 patients with pathologically confirmed lung adenocarcinoma who underwent complete resection at two medical centers. A VPI-DL model was developed using a four-layer convolutional neural network incorporating a novel attention mechanism trained on chest-wall-masked CT inputs. The model was trained on 692 cases and externally validated on an independent cohort of 143 patients. Performance was benchmarked against the consolidation-to-tumor ratio (CTR), a published DL model, and assessments by three thoracic surgeons. Evaluation metrics included area under the curve (AUC), sensitivity, specificity, and accuracy under a high-sensitivity operating threshold. RESULTS: In external validation, VPI-DL achieved an AUC of 0.91, sensitivity of 91%, specificity of 82%, and accuracy of 83%, outperforming the CTR (specificity 63%), the previously published model (specificity 54%), and thoracic surgeons (specificity 57%) at comparable sensitivity levels. The attention-guided architecture effectively reduced spurious correlations and improved interpretability. CONCLUSION: The proposed VPI-DL model improves the specificity of VPI prediction while preserving high sensitivity. By intentionally excluding chest wall information, the model offers a robust and interpretable tool to aid preoperative planning and minimize the risk of both under- and overtreatment in early-stage lung adenocarcinoma.

Authors

Keywords

No keywords available for this article.